Accelerate Your Lateral Flow Development
Arista Biologicals delivers high-performance antibodies, antigens, and colloidal gold conjugates engineered for lateral flow assay (LFA) formats in drugs of abuse (DOA) testing. Our comprehensive portfolio enables accurate detection of critical analytes, including amphetamine, benzoylecgonine, cannabinoid (THC), fentanyl, methamphetamine, and morphine, with matched antibody pairs and antigen conjugates (BSA- or BTG-labeled) designed to simplify your workflow.
Why Choose Arista Biologicals
Validated for LFA applications to reduce development risk
Consistent performance across batches for reproducible results
Scalable supply options to support pilot runs through full-scale production
Partner with us to overcome common challenges in DOA rapid test development and bring reliable products to market faster
Download The Brochure >
Validation Matters
In DOA testing, data accuracy starts with the right reagents. Whether your target analyte, assay platform, or sample type varies, success depends on high-quality materials validated for your application. Our reagents deliver:
Validated for LFA applications to reduce development risk
Consistent performance across batches for reproducible results
Scalable supply options to support pilot runs through full-scale production
Challenges We Help Solve
Cross-reactivity can lead to false positives
Lot-to-lot variations can disrupt assay reproducibility
Supply constraints during scale-up can lead to missed opportunities
Ready to Streamline Your DOA LFA Development?
Explore our full range of antibodies, antigens, and conjugates designed for rapid test manufacturers. Contact us today to discuss your project needs.
Product Pairings For Reliable Lateral Flow Performance
Find all the components you need for your drugs-of-abuse assay in one place. We offer matched antibody-antigen pairs along with pre-conjugated colloidal gold antibodies, saving you valuable time by eliminating the need for in-house conjugation. Explore our comprehensive portfolio designed to streamline development and ensure reliable lateral flow performance.
Stimulants
Well-characterized monoclonal antibodies against the West Nile virus envelope protein bind strongly to viral surface antigens from multiple lineages, enabling sensitive detection of intact virus while reducing cross‑reactivity with other flaviviruses.
| Amphetamine | Cutoff | Antigen Cat. No. | Antibody Cat. No. |
|---|---|---|---|
| 1,000 ng/mL | AGAMP-0310 > | ABAMP-0400 > | |
| 500 ng/mL | AGAMP-0315 > | ||
| 50 ng/mL | AGAMP-0316 > | ||
| Colloidal Gold Conjugate | CGAMP-0700 > | ||
| Methylenedioxymeth-amphetamine (MDMA) | Cutoff | Antigen Cat. No. | Antibody Cat. No. |
| 500 ng/mL | AGMDM-0303 > | ABMDM-0401 > | |
| 50 ng/mL | AGMDM-0304 > | ||
| Colloidal Gold Conjugate | CGMDM-0701 > | ||
| Methamphetamine | Cutoff | Antigen Cat. No. | Antibody Cat. No. |
| 1,000 ng/mL | AGMET-0300 > | ABMET-0401 > | |
| 50 ng/mL | AGMET-0301 > | ||
| Colloidal Gold Conjugate | CGMET-0701 > | ||
| Benzoylecgonine (Cocaine) | Cutoff | Antigen Cat. No. | Antibody Cat. No. |
| 300 ng/mL | AGCOC-0302 > | ABCOC-0402 > | |
| 30 ng/mL | AGCOC-0303 > | ABCOC-0406 > | |
| Colloidal Gold Conjugate | CGCOC-0702 > | ||
| CGCOC-0706 > | |||
Depressants
Barbiturates and benzodiazepines are among the most frequently misused depressants, making accurate detection essential for reliable screening. Our high-performance antibodies, antigens, and conjugates are purpose-built for lateral flow assays, ensuring strong specificity and minimal cross-reactivity. With validated matched pairs and a secure, scalable supply chain, we partner with manufacturers to deliver consistent quality from concept to commercialization.
Opioids
Opioids, including morphine, codeine, and synthetic variants, remain a major focus in drug testing. Our advanced antibody and antigen solutions are engineered for exceptional sensitivity and selectivity in LFA formats. Backed by proven conjugates and dependable supply continuity, we help manufacturers achieve robust performance and confidence at every stage of production.
Cannabinoids & Synthetic Cannabinoids
Cannabinoids, such as THC, and emerging synthetic analogs present unique detection challenges. Our LFA antibodies and antigens are validated for lateral flow, delivering strong selectivity and minimal cross-reactivity for reliable performance. With scalable solutions and expert technical support, we empower LFA developers to deliver accurate, reliable results from prototype through full-scale manufacturing.
Antidepressants
Tricyclic antidepressants and related compounds are increasingly included in toxicology panels, demanding precise detection. Our validated antibodies and antigens deliver reliable sensitivity and specificity for LFA applications, minimizing cross-reactivity. With matched pairs and a robust supply network, we partner with manufacturers to ensure dependable performance from development to market launch.
Additional Resources
Control Line Systems For Lateral Flow Assays
Lateral Flow Assay Tests for Detecting Drugs of Abuse
Lateral Flow Assay Reagent Request
Talk With An Expert
Trust our high-quality lateral flow assay antibodies, antigens, and conjugates to support reliable performance and ensure dependable results for the clinical decisions that rely on your assays.
